136 related articles for article (PubMed ID: 6330842)
1. Inactivated poliovirus vaccine in Finland.
Oker-Blom N; Penttinen K; Weckström P
Rev Infect Dis; 1984; 6 Suppl 2():S461-2. PubMed ID: 6330842
[No Abstract] [Full Text] [Related]
2. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
Jarzabek Z; Kańtoch M
Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
[No Abstract] [Full Text] [Related]
3. Elimination of poliomyelitis in Finland.
Lapinleimu K
Rev Infect Dis; 1984; 6 Suppl 2():S457-60. PubMed ID: 6330841
[TBL] [Abstract][Full Text] [Related]
4. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
Yang C; Shi H; Zhou J; Liang Y; Xu H
Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
[TBL] [Abstract][Full Text] [Related]
5. [Studies on new attenuated strains of type I live poliovirus vaccine. II. Investigation on a series of field trials with "Zhong I9" strain].
Chen TQ; Li CZ; Ni SF; Shi M; Luo GX; Dong DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):373-7. PubMed ID: 6327097
[No Abstract] [Full Text] [Related]
6. Poliomyelitis vaccines: killed or live?
Br Med J; 1978 Sep; 2(6141):845-6. PubMed ID: 709087
[No Abstract] [Full Text] [Related]
7. Killed polio virus vaccine in the control of poliomyelitis in Finland.
Lapinleimu K
Ann Clin Res; 1982 Dec; 14(5-6):199-203. PubMed ID: 6303196
[No Abstract] [Full Text] [Related]
8. [Poliomyelitis: vaccination is still important].
Pregliasco F; Minolfi V; Binda S; Andreassi A; Profeta ML
Ann Ig; 1994; 6(4-6):675-84. PubMed ID: 8611242
[No Abstract] [Full Text] [Related]
9. Antigen content of inactivated poliovirus vaccine for use in a one- or two-dose regimen.
Salk J; Stoeckel P; van Wezel AL; Lapinleimu K; van Steenis G
Ann Clin Res; 1982 Dec; 14(5-6):204-12. PubMed ID: 7171229
[TBL] [Abstract][Full Text] [Related]
10. [Observations on immune persistence after vaccination with attenuated polio vaccine (author's transl)].
Shi OS
Zhonghua Yu Fang Yi Xue Za Zhi; 1981 May; 15(3):148-50. PubMed ID: 7307827
[No Abstract] [Full Text] [Related]
11. Immunity induced by inactivated poliovirus vaccine and excretion of virus.
Chin TD
Rev Infect Dis; 1984; 6 Suppl 2():S369-70. PubMed ID: 6330838
[TBL] [Abstract][Full Text] [Related]
12. Eradication of poliomyelitis in the United States. I. Live virus vaccine-associated and wild poliovirus disease.
Salk D
Rev Infect Dis; 1980; 2(2):228-42. PubMed ID: 6994207
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the vaccination against polio by live attenuated virus].
Becker Y
Harefuah; 1977 Dec; 93(12):419-21. PubMed ID: 611063
[No Abstract] [Full Text] [Related]
14. When can we stop using oral poliovirus vaccine?
Hull HF; Minor PD
J Infect Dis; 2005 Dec; 192(12):2033-5. PubMed ID: 16288363
[No Abstract] [Full Text] [Related]
15. Immunoglobulin a as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population.
Herremans T; Kimman TG; Conyn-Van Spaendonck MA; Buisman A; de Melker H; Abbink F; Bijkerk P; Koopmans MP
Clin Infect Dis; 2002 Apr; 34(8):1067-75. PubMed ID: 11914995
[TBL] [Abstract][Full Text] [Related]
16. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
17. Poliomyelitis vaccines: an appraisal after 25 years.
Melnick JL
Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
[No Abstract] [Full Text] [Related]
18. Experience of vaccination with inactivated poliomyelitis vaccines in Iceland.
Gudnadóttir M
Dev Biol Stand; 1981; 47():257-9. PubMed ID: 7227654
[TBL] [Abstract][Full Text] [Related]
19. [The use of inactivated polio vaccine to prevent polio paralysis associated with the vaccination of children living in orphanages].
Ion-Nedelcu N; Crăciun D; Strebel P; Ciufecu C
Bacteriol Virusol Parazitol Epidemiol; 1997; 42(4):243-8. PubMed ID: 9586335
[No Abstract] [Full Text] [Related]
20. Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.
Dragunsky EM; Ivanov AP; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
J Infect Dis; 2006 Sep; 194(6):804-7. PubMed ID: 16941347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
